KIYATEC Announces Investment from Seae Ventures and Names Co-founder and Managing Partner Jason Robart to its Board of Directors

01 May, 2021

KIYATEC Announces Investment from Seae Ventures and Names Co-founder and Managing Partner Jason Robart to its Board of Directors
Photo by Adeolu Eletu on Unsplash

– KIYATEC, Inc secured a $2.5m investment from Seae Ventures.
– The investment comes on the heels of other recent announcements of success for KIYATEC.
– The company’s platform has been shown to be clinically predictive for patient-specific response to chemotherapy and targeted agents, and it has been analytically validated in both ovarian cancer and high-grade gliomas.
– KIYATEC has the potential to significantly improve outcomes for patients and their providers, not just for one cancer type, but across many solid tumors.

Biotechnology Health Diagnostics Life Science North America
Crunchbase icon

Content report

The following text will be sent to our editors: